Spire Wealth Management Has $877,000 Stake in Axon Enterprise, Inc $AXON

Spire Wealth Management decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 82.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,545 shares of the biotechnology company’s stock after selling 7,356 shares during the quarter. Spire Wealth Management’s holdings in Axon Enterprise were worth $877,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in AXON. NEOS Investment Management LLC raised its holdings in shares of Axon Enterprise by 82.7% during the 3rd quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock valued at $18,206,000 after purchasing an additional 11,482 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in Axon Enterprise by 3.3% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 184,423 shares of the biotechnology company’s stock worth $132,349,000 after buying an additional 5,953 shares during the last quarter. BIT Capital GmbH increased its position in Axon Enterprise by 75.6% during the third quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock worth $2,537,000 after buying an additional 1,522 shares during the last quarter. Finally, Legal & General Group Plc raised its holdings in Axon Enterprise by 3.1% during the third quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company’s stock valued at $302,208,000 after buying an additional 12,736 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 2.3%

Shares of AXON stock opened at $424.69 on Wednesday. The stock has a fifty day moving average price of $493.71 and a 200 day moving average price of $585.07. The stock has a market cap of $34.15 billion, a P/E ratio of 279.40, a price-to-earnings-growth ratio of 8.86 and a beta of 1.46. Axon Enterprise, Inc has a one year low of $396.41 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s revenue was up 38.5% on a year-over-year basis. During the same period last year, the business earned $2.08 earnings per share. Analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Piper Sandler reduced their price target on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Citigroup restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Craig Hallum reaffirmed a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Robert W. Baird set a $800.00 price target on Axon Enterprise in a report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $762.93.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 157 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total value of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at $567,910. The trade was a 11.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Erika Nardini sold 198 shares of the stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director owned 1,946 shares in the company, valued at $985,804.68. The trade was a 9.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 23,855 shares of company stock worth $13,299,928 over the last ninety days. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.